EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Diagnosis of Mucormycosis: Current Situation, Challenges and Future Prospects

Yixuan Qu, Yuling Xiao, Lina Liu, Junyan Qu

Mycoses · 2026-04 · 69 (4)

DOI: 10.1111/myc.70175 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Mycoses, online erschienen am 15.04.2026. Verfasst von Yixuan Qu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Rehabilitation School, Medical College, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Mucorales, Mucormycosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucormycosis, an aggressive fungal infection caused by members of the order Mucorales , progresses rapidly and is associated with high mortality, particularly in immunocompromised hosts such as patients with uncontrolled diabetes, transplant recipients or those with COVID‐19‐associated immunosuppression. Early diagnosis remains challenging with current clinical methods, yet it is essential to reduce mortality. This review examines the evolution of diagnostic strategies for mucormycosis, ranging from conventional techniques such as histopathology, culture and microscopy to advanced and emerging methods including molecular assays, serological testing, imaging and metabolomics. We also explore the ongoing transition towards integrated, rapid and non‐invasive diagnostic platforms that leverage novel biomarkers, portable devices and artificial intelligence. These new technologies have the potential to facilitate early diagnosis, thereby enabling early treatment and reducing the mortality rate of mucormycosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MucoralesMucormycosisHumansArtificial IntelligenceBiomarkersEarly DiagnosisImmunocompromised Host

Stichwörter der Autor:innen

artificial intelligenceearly diagnosisinvasive fungal diseasemucormycosisnovel diagnostics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Rehabilitation School, Medical College, Nanchang University, Nanchang, China.
  • Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Chengdu, China.
  • Laboratory of Pathogen Research, West China Hospital, Sichuan University, Chengdu, China.
  • Center of Infectious Disease, West China Hospital, Sichuan University, Chengdu, China.

Zitieren

APA

Qu, Y., Xiao, Y., Liu, L., & Qu, J. (2026). Diagnosis of Mucormycosis: Current Situation, Challenges and Future Prospects. Mycoses, 69(4). https://doi.org/10.1111/myc.70175

Vancouver

Qu Y, Xiao Y, Liu L, Qu J. Diagnosis of Mucormycosis: Current Situation, Challenges and Future Prospects. Mycoses. 2026;69(4). doi:10.1111/myc.70175

BibTeX
@article{Qu2026,
  author = {Qu, Yixuan and Xiao, Yuling and Liu, Lina and Qu, Junyan},
  title = {Diagnosis of Mucormycosis: Current Situation, Challenges and Future Prospects},
  journal = {Mycoses},
  year = {2026},
  volume = {69},
  number = {4},
  doi = {10.1111/myc.70175}
}
Kostenlos starten →